Literature DB >> 7923557

Relationship of cell survival, drug dose, and drug uptake after 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine treatment.

K Fujiwara1, L W Daniel, E J Modest, C A Wallen.   

Abstract

The mechanisms that govern the activity and the factors that control the anticancer activity of synthetic ether lipids have not been fully elucidated. In this study, three factors were studied in relationship to cell survival after treatment with 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine (ET-18-OCH3): (1) exposure dose, (2) drug uptake, and (3) cell density and cell-cycle distribution. In BG-1 human ovarian carcinoma cells, cell survival was an exponential function of exposure dose and was dependent on drug concentration. Drug uptake was dependent on the concentration of ET-18-OCH3, whereas the reduction in cell survival was directly related to the uptake of drug only in the first decade of cell kill. When the quantity of cells per flask was tripled from 4 to 12 x 10(6) cells, ET-18-OCH3 failed to induce a G2 block. Furthermore, the cell kill induced by a 72-h exposure to 2 microM ET-18-OCH3 was decreased by a factor of 2 when the cell density increased. Therefore, exposure dose and cell density are important parameters in determining the cell kill induced by ET-18-OCH3.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7923557     DOI: 10.1007/bf00685657

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  12 in total

1.  Quantitative analysis of phospholipids by thin-layer chromatography and phosphorus analysis of spots.

Authors:  G Rouser; A N Siakotos; S Fleischer
Journal:  Lipids       Date:  1966-01       Impact factor: 1.880

2.  Characterization of a human ovarian carcinoma cell line with estrogen and progesterone receptors.

Authors:  K R Geisinger; T E Kute; M J Pettenati; C E Welander; Y Dennard; L A Collins; M E Berens
Journal:  Cancer       Date:  1989-01-15       Impact factor: 6.860

3.  Role of cell cholesterol in modulating antineoplastic ether lipid uptake, membrane effects and cytotoxicity.

Authors:  L Diomede; A Bizzi; A Magistrelli; E J Modest; M Salmona; A Noseda
Journal:  Int J Cancer       Date:  1990-08-15       Impact factor: 7.396

4.  Tumor cell kinetics following antineoplastic ether phospholipid treatment.

Authors:  P Principe; C Sidoti; P Braquet
Journal:  Cancer Res       Date:  1992-05-01       Impact factor: 12.701

5.  Role of endocytosis in the action of ether lipids on WEHI-3B, HL60, and FDCP-mix A4 cells.

Authors:  G W Bazill; T M Dexter
Journal:  Cancer Res       Date:  1990-12-01       Impact factor: 12.701

6.  Cytotoxic interactions of heat and an ether lipid analogue in human ovarian carcinoma cells.

Authors:  K Fujiwara; E J Modest; C E Welander; C A Wallen
Journal:  Cancer Res       Date:  1989-11-15       Impact factor: 12.701

7.  Evidence of protein kinase C involvement in phorbol diester-stimulated arachidonic acid release and prostaglandin synthesis.

Authors:  J Parker; L W Daniel; M Waite
Journal:  J Biol Chem       Date:  1987-04-15       Impact factor: 5.157

8.  Autologous bone marrow transplantation in acute leukemia with marrow purged with alkyl-lysophospholipid.

Authors:  W R Vogler; W E Berdel; A C Olson; E F Winton; L T Heffner; D S Gordon
Journal:  Blood       Date:  1992-09-15       Impact factor: 22.113

9.  Cytotoxicity and metabolism of alkyl phospholipid analogues in neoplastic cells.

Authors:  D R Hoffman; L H Hoffman; F Snyder
Journal:  Cancer Res       Date:  1986-11       Impact factor: 12.701

Review 10.  Membrane-interactive lipids as experimental anticancer drugs.

Authors:  W E Berdel
Journal:  Br J Cancer       Date:  1991-08       Impact factor: 7.640

View more
  2 in total

1.  Growth inhibitory effects of liposome-associated 1-O-octadecyl-2-O-methyl-sn-glycero-3-phosphocholine.

Authors:  A C Peters; I Ahmad; A S Janoff; M Y Pushkareva; E Mayhew
Journal:  Lipids       Date:  1997-10       Impact factor: 1.880

2.  The orally available, synthetic ether lipid edelfosine inhibits T cell proliferation and induces a type I interferon response.

Authors:  Pierre Abramowski; Benjamin Otto; Roland Martin
Journal:  PLoS One       Date:  2014-03-25       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.